Compare · CHEK vs GEHC
CHEK vs GEHC
Side-by-side comparison of Check-Cap Ltd. (CHEK) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHEK and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $27.76B, about 1305.4x CHEK ($21.3M).
- GEHC has hit the wire 14 times in the past 4 weeks while CHEK has been quiet.
- GEHC has more recent analyst coverage (25 ratings vs 1 for CHEK).
- Company
- Check-Cap Ltd.
- GE HealthCare Technologies Inc.
- Price
- -
- -
- Market cap
- $21.3M
- $27.76B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- News (4w)
- 0
- 14
- Recent ratings
- 1
- 25
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.
Latest CHEK
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- MBody AI and Check-Cap Enter into Definitive Merger Agreement
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 20-F filed by Check-Cap Ltd.
- Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime
Latest GEHC
- Chief Financial Officer Saccaro James bought $200,585 worth of shares (3,310 units at $60.60), increasing direct ownership by 4% to 87,471 units (SEC Form 4)
- GC & Corporate Secretary Jimenez Frank R bought $105,788 worth of shares (1,750 units at $60.45), increasing direct ownership by 2% to 93,932 units (SEC Form 4)
- President and CEO Arduini Peter J bought $249,827 worth of shares (4,169 units at $59.92), increasing direct ownership by 2% to 259,424 units (SEC Form 4)
- GE HealthCare downgraded by Goldman with a new price target
- SEC Form 10-Q filed by GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GE HealthCare reports first quarter 2026 financial results
- GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
- GE HealthCare management to present at upcoming investor conferences
- GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents